A Prevalence of Brain Disorders
Over 50% of the world will suffer from a serious brain disorder at some point in their lifetime. Treatment is complicated by ambiguous symptom associations and the immense complexity of mapping a disorder to its exact origin in the central nervous system.
Our platform is developed to address these issues and bring new, more effective therapies to market.
Current number of adults in the United States with:
Brain disorders are difficult to treat and have a profound health and economic impact
Diseases of the brain impose
- massive health economic costs (billions of dollars each year in US)
- devastating impact on patients (health costs, loss of work, suicide)
Comorbidities are common (e.g. anxiety & depression)
Diagnoses can be ambiguous
Symptoms are not exclusive to individual disorders
- Anhedonia is a symptom of depression, Parkinson’s, Alzheimer’s, addiction, schizophrenia & others
- Anxiety is a symptom of depression, Parkinson’s, Alzheimer’s, addiction, schizophrenia & others
There’s a lot at stake, at the individual, familial, community and global levels. Eighty-six million adults in the United States alone suffer from CNS disorders, and current treatments are difficult to define and difficult to assess. In many cases there simply is no effective treatment. MapLight Has already shown promise in these areas, and this is just the beginning.